76 related articles for article (PubMed ID: 19930022)
1. Poor criterion validity of self-reported hepatitis B infection and vaccination status among injecting drug users: a review.
Topp L; Day C; Dore GJ; Maher L
Drug Alcohol Rev; 2009 Nov; 28(6):669-75. PubMed ID: 19930022
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus among injecting drug users in Sydney, Australia: prevalence, vaccination and knowledge of status.
Day CA; White B; Dore GJ; van Beek I; Rodgers C; Cunningham P; Wodak A; Maher L
Drug Alcohol Depend; 2010 Apr; 108(1-2):134-7. PubMed ID: 20047803
[TBL] [Abstract][Full Text] [Related]
3. Poor validity of self-reported hepatitis B virus infection and vaccination status among young drug users.
Kuo I; Mudrick DW; Strathdee SA; Thomas DL; Sherman SG
Clin Infect Dis; 2004 Feb; 38(4):587-90. PubMed ID: 14765355
[TBL] [Abstract][Full Text] [Related]
4. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
[TBL] [Abstract][Full Text] [Related]
5. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
[TBL] [Abstract][Full Text] [Related]
6. Poor validity of self-reported HBV vaccination among young heroin users in Spain supports the policy "don't ask, draw a blood sample, vaccinate and try to schedule another visit".
de la Fuente L; Toro C; Brugal MT; Vallejo F; Soriano V; Barrio G; Ballesta R; Bravo MJ;
J Clin Virol; 2007 Jan; 38(1):87-90. PubMed ID: 17088099
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination.
Carter H; Robinson G; Hanlon C; Hailwood C; Massarotto A
N Z Med J; 2001 Jul; 114(1136):324-6. PubMed ID: 11548096
[TBL] [Abstract][Full Text] [Related]
8. Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ
Vaccine; 2006 Mar; 24(13):2377-86. PubMed ID: 16384627
[TBL] [Abstract][Full Text] [Related]
9. Changing serological status and low vaccination-induced protection rates against hepatitis B characterize chronic hepatitis C virus-infected injecting drug users in Greece: need for immunization policy.
Elefsiniotis IS; Pantazis KD; Ketikoglou ID; Koutsounas SI; Tsianos EV
Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1227-31. PubMed ID: 17033445
[TBL] [Abstract][Full Text] [Related]
10. Two simultaneous hepatitis B virus epidemics among injecting drug users and men who have sex with men in Buenos Aires, Argentina: characterization of the first D/A recombinant from the American continent.
Trinks J; Cuestas ML; Tanaka Y; Mathet VL; Minassian ML; Rivero CW; Benetucci JA; Gímenez ED; Segura M; Bobillo MC; Corach D; Ghiringhelli PD; Sánchez DO; Avila MM; Peralta LA; Kurbanov F; Weissenbacher MC; Simmonds P; Mizokami M; Oubiña JR
J Viral Hepat; 2008 Nov; 15(11):827-38. PubMed ID: 18507755
[TBL] [Abstract][Full Text] [Related]
11. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005.
Sunthornchart S; Linkins RW; Natephisarnwanish V; Levine WC; Maneesinthu K; Lolekha R; Tappero JW; Trirat N; Muktier S; Chancharastong P; Fox K; Donchalermpak S; Vitek C; Supawitkul S
Addiction; 2008 Oct; 103(10):1687-95. PubMed ID: 18705685
[TBL] [Abstract][Full Text] [Related]
13. Impact of a targeted hepatitis B vaccination program in Amsterdam, The Netherlands.
van Houdt R; Sonder GJ; Dukers NH; Bovee LP; van den Hoek A; Coutinho RA; Bruisten SM
Vaccine; 2007 Mar; 25(14):2698-705. PubMed ID: 16919856
[TBL] [Abstract][Full Text] [Related]
14. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy.
Hahné S; Ramsay M; Balogun K; Edmunds WJ; Mortimer P
J Clin Virol; 2004 Apr; 29(4):211-20. PubMed ID: 15018847
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users.
Ferreira RC; Rodrigues FP; Teles SA; Lopes CL; Motta-Castro AR; Novais AC; Souto FJ; Martins RM
J Med Virol; 2009 Apr; 81(4):602-9. PubMed ID: 19235862
[TBL] [Abstract][Full Text] [Related]
16. Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users.
Campbell JV; Garfein RS; Thiede H; Hagan H; Ouellet LJ; Golub ET; Hudson SM; Ompad DC; Weinbaum C;
Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S64-72. PubMed ID: 17276018
[TBL] [Abstract][Full Text] [Related]
17. Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?
Judd A; Hickman M; Hope VD; Sutton AJ; Stimson GV; Ramsay ME; Gill ON; Parry JV
J Viral Hepat; 2007 Aug; 14(8):584-91. PubMed ID: 17650293
[TBL] [Abstract][Full Text] [Related]
18. Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons.
Hutchinson SJ; Wadd S; Taylor A; Bird SM; Mitchell A; Morrison DS; Ahmed S; Goldberg DJ
Vaccine; 2004 Nov; 23(2):210-4. PubMed ID: 15531039
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B infection and vaccination among high-risk noninjection drug-using women: baseline data from the UNITY study.
Koblin BA; Xu G; Lucy D; Robertson V; Bonner S; Hoover DR; Fortin P; Latka M
Sex Transm Dis; 2007 Nov; 34(11):917-22. PubMed ID: 17579337
[TBL] [Abstract][Full Text] [Related]
20. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
